TERMINATED

Comparison of Quadratus Lumborum Block Types

Talk to us

Conditions

PainOpioid UseLumbar Disc HerniationLumbar SpineNerve Block

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will compare the quality of analgesia and reduction of opioid use, between standard of care and two groups of local anesthetic blocks in different location in the quadratus lumborum plane, for postoperative pain control after lumbar spinal fusion and if it reduces opioid consumption.

Official Title

Comparison of Quadratus Lumborum Block With Medical Management for Pain Control After Lumbar Spine Fusion Surgery

Quick Facts

Study Start:2020-12-01
Study Completion:2021-05-14
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT04588389

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult Patients undergoing lumbar spinal fusion surgery.
  2. * Patients from 40-80 years.
  1. * Recent drug abuse
  2. * History of illicit drug use
  3. * Chronic pain patients not related to the back lesions.
  4. * Opioid tolerant patients.
  5. * Patients with any lower extremity weaknesses or deficits.
  6. * Patients with American Society of Anesthesiologists (ASA) classification more than 3.
  7. * Coagulopathy.
  8. * Infection near or in the area of the block.
  9. * Pregnant patients.
  10. * Uncooperative patients who refuse care which directly effects research participation or clinical care.
  11. * If the surgeon reports performing non-typical fusion.
  12. * The presence of intraoperative complications like nerve injury or abnormal results of neuromonitoring and extensive dissection.
  13. * Vulnerable populations (prisoner, mental impairment / dementia, pregnant, etc.)
  14. * Subjects on chronic buprenorphine therapy (either for opioid replacement or pain control)

Contacts and Locations

Principal Investigator

Eman Nada, MD
PRINCIPAL_INVESTIGATOR
University of Massachusetts, Worcester
Alexander Chan, MD
PRINCIPAL_INVESTIGATOR
University of Massachusetts, Worcester

Study Locations (Sites)

UMASS Memorial Medical Center
Worcester, Massachusetts, 01605
United States

Collaborators and Investigators

Sponsor: University of Massachusetts, Worcester

  • Eman Nada, MD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Worcester
  • Alexander Chan, MD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Worcester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-01
Study Completion Date2021-05-14

Study Record Updates

Study Start Date2020-12-01
Study Completion Date2021-05-14

Terms related to this study

Keywords Provided by Researchers

  • Lumbar Spine
  • Nerve Block
  • Opioid Use
  • Pain

Additional Relevant MeSH Terms

  • Pain
  • Opioid Use
  • Lumbar Disc Herniation